Recently, the "2018 China Pharmaceutical Industry Most Influential List Press Conference and the 11th China Pharmaceutical Industry Development Summit Forum" hosted by the Medical and Pharmaceutical Chamber of Commerce of the All China Federation of Industry and Commerce was successfully held in Jinan, Shandong. At the meeting, the "2018 China Pharmaceutical Industry Top 100 Series List" was announced. Zheng Cheng Yi Pharmaceutical Co., Ltd. stood out in the industry with its professional technological innovation strength and good brand reputation, and for the first time, ranked on the "2018 China Pharmaceutical Industry (Chemical Pharmaceutical) Top 100" list. Since its publication in 2006, this list has become one of the most closely watched and authoritative pharmaceutical rankings in China for more than ten consecutive years.
The "Series List" is divided into five sub lists: "Top 100 List of Chinese Chemical Pharmaceutical Enterprises", "Top 100 List of Chinese Traditional Chinese Medicine Enterprises", "Top 20 List of Chinese CRO (including CDMO) Enterprises", "Top 20 List of Chinese Medical Device (including IVD) Enterprises", and "Top 20 List of Chinese Biomedical (including blood products, vaccines, insulin, etc.) Enterprises", focusing on the innovation driving force and professional promotion force of domestic pharmaceutical industry enterprises, A total of 260 companies are listed. Among them, the "Top 100 Chinese Chemical and Pharmaceutical Enterprises Ranking List" is based on the comprehensive evaluation of the R&D and terminal sales indicators of the shortlisted enterprises. The R&D comprehensive indicator score accounts for 40% of the weight, and the terminal sales indicator score accounts for 60% of the weight.
General Manager Zhao Chunjian, Executive Vice General Manager Li Shisheng, and Vice General Manager Dong Mi Ke Zehui participated in the event held in Jinan, Shandong on July 15th. (Wu Fengxu)